Fastenal Company Common Stock vs GSK plc — how do they compare? Fastenal Company Common Stock trades at $50.58 (market cap $57.94B), while GSK plc trades at $46.41 (market cap $91.88B). The key difference: GSK plc is the larger of the two by market cap, and GSK plc pays the higher dividend (3.9%). Which is the better fit depends on your goals — on Pluang, investors hold Fastenal Company Common Stock for 0 Days and GSK plc for 93 Days on average.
| FAST | GSK | |
|---|---|---|
Market Cap | $57.94B | $91.88B |
Volume | 6,764,575 | 7,730,529 |
Sector | Industrials | Health |
52-Week High | $52.38 | $61.18 |
52-Week Low | $39.15 | $43.24 |
Typical Hold Time | 0 Days | 93 Days |
Enterprise Value | $58.17B | $111.88B |
Dividend Yield | 1.9% | 3.9% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GSK trades at $47.02, up 0.9% with a P/E of 14.89, trading below industry averages. The stock shows strong profitability with 72.73% gross margins and 29.73% ROE, though technical indicators signal bearish momentum. Recent earnings beats and strategic oncology investments highlight growth potential amid patent cliff concerns.
GSK's valuation appears attractive with earnings momentum, but faces headwinds from technical weakness and HIV patent expirations. The bullish analyst sentiment (31% buy ratings) and pipeline innovation provide upside, while cost-saving initiatives and dividend yield offer stability. Key risks include competitive pressures and execution on £40B sales targets.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Fastenal distributes fasteners, tools, safety supplies, and other industrial products. It also provides inventory management and vending solutions for business customers.
Read more on FAST →In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →